Peptide stacks · Growth hormone
Tesamorelin and ipamorelin stack: what’s in it and the evidence
Checked against our library and study pagesPublished by PepVault
The tesamorelin and ipamorelin stack is two compounds run side by side, each from its own vial or form: tesamorelin and ipamorelin. The library records tesamorelin at 1–2 mg and ipamorelin at 200–300 mcg per dose as reference ranges.
This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.
What’s in the tesamorelin and ipamorelin stack
| Part | Reference range | Filed under | Evidence (library) |
|---|---|---|---|
| Tesamorelin | 1–2 mg | Visceral fat loss, FDA-approved use, Body composition | Established |
| Ipamorelin | 200–300 mcg | GH release, Sleep quality, Recovery | Moderate |
The library’s reference range per dose, part by part
Tesamorelin
Tesamorelin is one of the two parts of the tesamorelin and ipamorelin stack. The only GHRH analog currently FDA-approved (to reduce excess abdominal fat in HIV lipodystrophy).
Ipamorelin
Ipamorelin is one of the two parts of the tesamorelin and ipamorelin stack. Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.

Has the tesamorelin and ipamorelin stack been studied as a combination?
None of our 436 study pages tested tesamorelin and ipamorelin together, so the tesamorelin and ipamorelin stack rests on studies of its parts and on community reports.
The studies of the parts, one by one: 12 study pages on tesamorelin (12 in people) and 10 study pages on ipamorelin (1 in people).
| Part | Study pages | In people | Strongest study page |
|---|---|---|---|
| Tesamorelin | 12 | 12 | Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy (meta-analysis, 2026) |
| Ipamorelin | 10 | 1 | Ipamorelin did not speed first meal after bowel surgery vs placebo (randomized trial, 2014) |
What people commonly report on the tesamorelin and ipamorelin stack
The library holds no report of what people notice on the tesamorelin and ipamorelin stack as a pair. What it records for each part on its own:
- Tesamorelin: waist and belly shrinking while body weight barely moves, with injection-site redness and early joint aches.
- Ipamorelin: deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6.
These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.
Why these are combined
“Tesamorelin + Ipamorelin leans on visceral fat”, the library’s note on the pair (clinical data)
Tesamorelin is the GHRH analog with the strongest clinical data for visceral (deep abdominal) fat reduction; Ipamorelin adds the selective GH pulse on top. If the goal is the stubborn midsection rather than general GH optimization, this is the more evidence-backed GHRH choice. Same fasted-timing rules apply — keep it away from food for the cleanest pulse.
How the parts of the tesamorelin and ipamorelin stack are mixed and taken
The tesamorelin and ipamorelin stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.
| Part | Route | How often | Our vial pages |
|---|---|---|---|
| Tesamorelin | SubQ injection | Daily | 2 mg vial, 10 mg vial |
| Ipamorelin | SubQ injection, IM injection | 2–3x daily, best fasted or before bed | 5 mg vial |
Our vial pages work out the mix for each part’s own vial, size by size:
Compared with running the parts apart
The library’s notes on the tesamorelin and ipamorelin stack don’t compare it with running either part on its own.
Safety notes
The library holds no combination safety note on the tesamorelin and ipamorelin stack, so each part’s own notes apply, on its compound page.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Questions people ask
What is in the tesamorelin and ipamorelin stack?
The tesamorelin and ipamorelin stack is two compounds run side by side, each from its own vial or form: tesamorelin and ipamorelin. The library records tesamorelin at 1–2 mg and ipamorelin at 200–300 mcg per dose as reference ranges.
Has the tesamorelin and ipamorelin stack been studied together?
Not as a combination in any of our study pages: the tesamorelin and ipamorelin stack rests on studies of its parts and on community reports.
Do the parts of the tesamorelin and ipamorelin stack come in one vial?
No: in the library each part of the tesamorelin and ipamorelin stack is its own compound with its own route and schedule (tesamorelin by SubQ injection and ipamorelin by SubQ injection).
What does each part of the tesamorelin and ipamorelin stack do?
Tesamorelin: The only GHRH analog currently FDA-approved (to reduce excess abdominal fat in HIV lipodystrophy). Ipamorelin: Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.